Alkalax

Quick links to important sections

Alkalax

Method of action: Laxative

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Alkalax

The pharmaceutical entity Alkalax is a trade name for a medication whose core ingredient is Bisacodyl, placing it within the pharmacological class of stimulant laxatives. This medication is fundamentally defined by its synthetic origin and its localized activity within the lower gastrointestinal tract.


Property Description
Active ingredient Bisacodyl (Diphenylmethane derivative)
Form Gastro-resistant tablets, Suppositories, Enemas
Pharmacological class Stimulant laxative, Cathartic (ATC code A06AB02)
General purpose Relief of occasional constipation or irregularity
Origin Synthetic derivative (Prodrug)

What Type of Medicine is Alkalax and What is it Made Of?

Alkalax is classified as a stimulant laxative, or cathartic, designed to enhance bowel motility. Its active ingredient, Bisacodyl, is a synthetic diphenylmethane derivative that functions as a prodrug. This means the compound itself is largely inactive until it undergoes transformation by intestinal enzymes in the colon, yielding the therapeutically active component, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM).

This medication's classification, designated by the Anatomical Therapeutic Chemical (ATC) code A06AB02, specifies its role in promoting bowel evacuation. Unlike bulk-forming agents, Alkalax achieves its effect by directly stimulating the nerves in the colon wall.

Delivery Forms and General Purpose

Alkalax is available as a single-entity product in several distinct dosage form(s), including gastro-resistant tablets for oral administration, and suppositories or enemas for rectal administration. The tablets are specifically formulated with an enteric coating to ensure the Bisacodyl is delivered directly to the colon, bypassing stomach acid. The general purpose of Alkalax is to relieve constipation or irregularity by promoting efficient and rapid bowel evacuation.

Its design ensures that the active substance reaches the large intestine intact, where it exerts its local action by increasing intestinal muscle contractions (peristalsis) and encouraging water and salt secretion into the bowel lumen, ultimately softening the stool and accelerating its passage. Bisacodyl facilitates bowel movements, such as when preparing for a medical procedure. This mechanism provides a pathway for temporary relief of irregularity, for use on a short-term basis.

Regulatory References

  1. DailyMed: Bisacodyl

What side effects are possible with Alkalax?

Possible side effects and safety information

The safety profile of Alkalax (Bisacodyl) is defined by officially documented adverse reactions classified by frequency and the organ systems affected, as standardized in regulatory documents. These classifications establish the expected risks associated with the stimulant laxative.

Frequency-Classified Adverse Reactions

The most commonly reported side effects, classified as Common, are linked to the drug's action in the gastrointestinal tract and include abdominal pain, abdominal cramps, and diarrhea. Events classified as Uncommon include nausea, vomiting, abdominal discomfort, and dizziness, with syncope (fainting) also noted as a potential vasovagal response to the abdominal discomfort.

Serious and Exposure-Related Safety Patterns

Official regulatory documentation identifies Rare but serious adverse reactions, which fall under the Immune System Disorders and include hypersensitivity reactions such as angioedema and anaphylactic reactions. Furthermore, the safety profile includes rare reports of serious bowel conditions, such as colitis.

Safety limitations explicitly address the pattern of use. Prolonged or excessive use is associated with the risk of fluid and electrolyte imbalance, specifically hypokalaemia (low potassium). Regulatory authorities also document that extended use may lead to laxative dependence.

For forms administered rectally (suppositories or enemas), specific local risks documented include local irritation, burning, and proctitis.

Safety Considerations

The risk of electrolyte imbalance is heightened when Alkalax is administered concurrently with other medications that affect electrolyte levels, such as certain diuretics or corticosteroids. Regulatory guidance notes that use in the first trimester of pregnancy should be medically assessed due to limited available safety data.

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the officially documented manifestations and mandated emergency actions for an overdose of Alkalax (Bisacodyl), as specified in governmental regulatory labeling.

Documented Manifestations and Severe Outcomes

Acute overdose due to excessive single doses is officially documented to present with gastrointestinal symptoms including severe abdominal pain, cramping, and diarrhea. These effects are an exaggeration of the drug's localized action.

Chronic high-dose misuse is associated with more severe systemic complications, including severe dehydration and critical electrolyte imbalance, particularly hypokalemia (low potassium). Long-term abuse may result in renal tubule damage and secondary hyperaldosteronism, as noted in official prescribing information.

Emergency Actions Mandated by Regulators

Situation Mandated Action (as per Official Labeling)
Suspected Overdose or Severe Symptoms Seek immediate medical attention or contact a Poison Control Center.
Management Protocol Symptomatic and supportive treatment is required, focusing on the correction of severe fluid and electrolyte imbalance.
Antidote Availability No specific antidote is known for Bisacodyl overdose.

Immediate medical care is required upon the onset of severe or persistent symptoms, such as muscle weakness or signs of severe fluid loss. Hospital monitoring may be required for patients exhibiting significant electrolyte disturbances.

Therapeutic Uses of Alkalax

Alkalax, which contains the active ingredient sodium picosulfate, belongs to the category of stimulant laxatives. The primary therapeutic area is considered relevant to provide short-term symptomatic assistance for conditions presenting with acute or disruptive episodes of functional constipation, which addresses symptoms that interfere with daily functioning by promoting a bowel movement. This medication is relevant for easing symptoms that interfere with daily comfort, and it may assist in the management of specific clinical scenarios such as colon cleansing before certain medical procedures or surgery.

It is generally used when supportive symptom management is appropriate for conditions presenting with systemic or localized discomfort associated with infrequent or difficult bowel movements. Its function contributes to improved comfort during periods of heightened symptoms. This supportive relief may help maintain a sense of stability when symptoms are more noticeable, and may assist with maintaining functional stability.

Quick Fact: Relief for symptoms related to physical discomfort

“The product may assist with easing the overall symptom load during episodes of heightened discomfort.”

Regulatory References

  1. Summary of Product Characteristics (SmPC) from the Irish Health Products Regulatory Authority

Eligibility and Restrictions for Use

Alkalax (Bisacodyl) is subject to specific usage rules defined by official regulatory bodies, focusing on patient eligibility and absolute exclusions.

Contraindications and Non-Eligibility

Alkalax is contraindicated (must not be used) in patients with severe, pre-existing conditions, including intestinal obstruction or ileus, acute inflammatory bowel diseases, acute abdominal conditions such as appendicitis, and severe dehydration. Use is also prohibited if severe abdominal pain is present alongside nausea and vomiting, or in cases of known hypersensitivity to the drug or its components. Due to excipients, the tablets are also contraindicated in rare hereditary sugar intolerances (e.g., galactosaemia).

Age-Related and Conditional Use

  • Adults are generally eligible for use.
  • Pediatric Use is subject to strict minimum age limits, which vary by formulation and region (e.g., typically ge 12 years for tablets without medical advice). Treatment of chronic constipation in younger children must be supervised by a physician.
  • Pregnancy and Lactation: Use during pregnancy is generally not recommended, especially in the first trimester, unless on medical advice. The medication is generally considered compatible with breastfeeding.
  • Restrictions: Patients at risk of dehydration, such as those with renal insufficiency or the elderly, must discontinue use and seek medical supervision if fluid loss occurs.

What should I know about interactions with other medicines?

Alkalax Interactions with other medicines and products

Official regulatory information for Alkalax (Bisacodyl) describes interactions in two main categories: those affecting the product’s coating and those causing a shared effect on the body's fluid balance.

Category Official Regulatory Information
Timing-Separation Rules Oral tablets must not be taken within one hour of taking antacids or consuming milk products. This restriction is documented to prevent the premature dissolution of the tablet’s enteric coating in the stomach, which could alter the drug’s local exposure profile.
Interacting Substances Diuretics and Adreno-corticosteroids are documented to increase the risk of hypokalaemia (low potassium levels) if Alkalax is used excessively.
Pharmacodynamic Effect Electrolyte imbalance resulting from the use of Alkalax may increase patient sensitivity to the effects of Cardiac Glycosides (e.g., Digoxin). Co-administration with other laxatives may also enhance gastrointestinal side effects.
Metabolic/Transporter No interactions involving CYP enzymes or drug transporters are explicitly documented in the regulatory prescribing information.

Interaction notes include caution for elderly patients and individuals with renal insufficiency regarding the increased clinical significance of fluid loss and potential electrolyte disturbance that may result from excessive laxative use.

Mechanism of Action

How Alkalax Works

Alkalax’s core mechanism is mediated by its active metabolite, bis-(p-hydroxyphenyl)-pyridyl-2-methane ( BHPM), generated from the Bisacodyl prodrug by enzymatic conversion in the colon. This mechanism involves a dual action targeting both motor and secretory functions.

Dual Stimulation of Colonic Nerves and Muscle

BHPM directly stimulates the enteric nerve endings and longitudinal smooth muscle cells within the large intestine. This neural and muscular stimulation initiates a series of coordinated, powerful propulsive contractions known as High Amplitude Propagated Contractions ( HAPCs). The resulting physiological effect is a dramatic acceleration of colonic transit time, leading to a reduction in transit time.

Active Modulation of Fluid and Electrolyte Secretion

The active metabolite also targets the colonic enterocytes, activating the adenylate cyclase enzyme pathway. This molecular cascade drives the net secretion of electrolytes ( Cl^-, HCO3^-) and water into the intestinal lumen while simultaneously suppressing their reabsorption. The resulting physiological consequence is an increase in the intraluminal fluid volume, which increases the hydration of the luminal contents and complements the motor effects initiated by the muscle contractions.

Dosage and Administration Information

How to Use Alkalax

Alkalax, which contains bisacodyl, is administered according to standardized protocols and is generally intended for short-term use for occasional constipation. Its administration follows specific guidelines regarding route, timing, and duration.


Administration Routes and Dosing

Alkalax is available for both oral and rectal administration, utilizing two primary dosage forms: 5 mg gastro-resistant tablets and 10 mg suppositories. For adults, the standard oral dosing regimen for occasional constipation ranges from 5 mg to 10 mg taken as a single daily dose. The standard rectal dose is 10 mg (one suppository) administered as a single daily dose.


Administration Timing and Preparation

The timing of administration is controlled to optimize the onset of action. Oral tablets are typically taken at night or bedtime to produce an effect in 6 to 12 hours. Rectal suppositories, in contrast, are usually administered in the morning for a rapid effect, which occurs within 10 to 60 minutes.

Oral administration requires specific handling: the gastro-resistant tablets must be swallowed whole with an adequate amount of fluid and must not be chewed, crushed, or split. Furthermore, to ensure the integrity of the enteric coating, the tablets should not be taken within one hour of consuming antacids, milk, or dairy products.


Population-Specific and Duration Rules

Dosage guidelines include specific provisions for pediatric patients. Children aged 6 to 11 years are typically given 5 mg orally or rectally as a single daily dose. The medication is explicitly restricted to short-term treatment; continuous daily administration should not exceed five to seven days without clinical investigation of the cause of constipation. After regularity is established, the dose should be reduced and discontinued.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Alkalax


Evidence for use in Chronic Functional Constipation

The primary body of evidence for the active ingredient in Alkalax, Bisacodyl, comes from Randomized Controlled Trials (RCTs) and Systematic Reviews evaluated in adults with chronic functional constipation. This research has been used in exploring how symptoms change over defined intervals, usually limited to a few weeks.

Studies examined measurements like the frequency of Complete Spontaneous Bowel Movements (CSBMs) and stool consistency. Findings describe patterns observed where bowel movement frequency was compared against control groups. A key limitation, however, is that follow-up durations were limited in these high-quality controlled trials, meaning long-term outcomes are not fully established.


Evidence for use in Bowel Preparation Procedures

Bisacodyl was studied for use as a cathartic agent before certain medical investigations, such as colonoscopy. Research includes clinical trials examining the quality of bowel cleansing and the time to achieve effective evacuation.

The findings describe patterns where regimens incorporating Bisacodyl yielded measurements of cleansing quality that were deemed adequate for procedural requirements. However, as Bisacodyl is frequently studied as a component in multi-agent regimens, isolating its contribution to the final cleansing score can be challenging.


Symptom Relief and Quality of Life Measures

Researchers have also applied in studies examining patient-reported experiences to evaluate outcomes related to physical discomfort. These investigations used tools like the Patient Assessment of Constipation Quality of Life (PAC-QoL) questionnaire as secondary measures to monitor symptoms such as straining and bloating.

Studies document changes measured during the study period for these symptoms concurrently with changes in bowel frequency. However, because these symptom measurements were often secondary endpoints, the sample sizes were modest for detecting small changes, meaning the certainty about the extent of measured change for specific individual symptoms may vary.


Evidence Gaps and Special Populations

Research has explored the use of Bisacodyl in older adults and, separately, in pediatric patients. The available data in these groups remain distinct from the main adult evidence base, and evidence quality varies across studies depending on the specific age range. Overall, the primary gap is the limited information for long-term outcomes that would describe observed patterns of use over many months.

Key Studies & References

  1. Bisacodyl: Summary of Product Characteristics (SmPC) - License PA1009/024/002

Frequently Asked Questions (FAQ)

Common questions about Alkalax (FAQ)

Q: Is Alkalax considered a laxative or something else?

A: According to official regulatory documents, Alkalax (bisacodyl) is classified as a stimulant laxative. This class of medication is described as promoting a bowel movement by increasing the muscle contractions within the intestines.


Q: Can Alkalax interact with common vitamins or supplements?

A: Official regulatory documents do not explicitly list interactions with general vitamins or supplements. However, the product labeling recommends a general precaution to take Alkalax 2 hours before or after other drugs to help ensure that the product’s function is not unintentionally altered.


Q: Is it safe to use Alkalax if I am already taking prescription medication?

A: Official information documents specific interactions with certain drug classes, such as diuretics and corticosteroids, due to the potential risk of electrolyte imbalance. Official guidance emphasizes consulting a healthcare professional regarding specific potential interactions when taking other medications.


Q: Does Alkalax affect how other drugs are absorbed in the body?

A: Regulatory documents primarily advise taking Alkalax separately from products that reduce stomach acidity, such as antacids. This restriction is to prevent the premature release of the drug, helping ensure the drug is released where intended in the colon.


Q: What is the official safety classification given to Alkalax?

A: Alkalax (bisacodyl) is widely available and regulated as an Over-the-Counter (OTC) medication in many countries. This classification defines it as available without a prescription for short-term, occasional use.


Q: What types of food or drinks might interact with Alkalax?

A: The official product labeling specifically states that oral tablets should not be taken within one hour of consuming milk products. This is because milk can compromise the tablet's special coating, helping to maintain the integrity of the gastro-resistant coating.


Q: Why do official sources list specific warnings for Alkalax?

A: Official warnings are listed to provide patients with essential information regarding specific risks associated with overuse and use in certain pre-existing conditions, such as intestinal blockage and severe dehydration. They also warn of the risks of chronic overuse, including fluid/electrolyte loss and laxative dependence.


Q: What do patient information leaflets say about Alkalax and stomach cramps?

A: Official patient information confirms that abdominal pain and abdominal cramps are classified as Common side effects. These events are frequently reported and are related to the drug's effect of increasing intestinal muscle activity.


Q: Are there different brand names for the same active ingredient as Alkalax?

A: Yes, the active ingredient in Alkalax, Bisacodyl, is a widely recognized compound. It is marketed under several other trade names internationally and is also commonly available generically.


Q: What are the common misunderstandings about how Alkalax should be used?

A: Official instructions emphasize two key points: the product is strictly for short-term use only (less than 7 days), and the tablets must be swallowed whole without crushing or chewing to help ensure the product's intended action is maintained.


Q: Is it normal to feel slightly bloated after taking Alkalax?

A: While 'bloating' is not specifically listed in the official side effect classification, regulatory documents do commonly report related adverse events like abdominal discomfort and abdominal cramps. These symptoms are connected to the drug’s action of increasing muscle activity in the digestive tract.


Q: How is Alkalax different from common over-the-counter stomach relief medicines?

A: Alkalax is primarily a stimulant laxative that actively promotes bowel movement through muscle contraction. This is a different class of action than antacids (which neutralize stomach acid) or stool softeners (which soften stool consistency).


Q: Is it true that Alkalax works on the acidity level in the stomach?

A: No. Alkalax is a locally acting laxative that is chemically designed to resist stomach acid. It is formulated to be a locally acting laxative and is designed to resist stomach acid until it reaches the large intestine.


Q: Does taking Alkalax at a certain time of day matter?

A: Yes. The timing of administration affects when the bowel movement will occur. Oral tablets are typically taken at night or bedtime to produce the expected effect within 6 to 12 hours. Rectal forms, conversely, act rapidly, usually within 10 to 60 minutes.


Q: What happens if someone accidentally takes too much Alkalax?

A: Regulatory sources document that high doses can lead to watery stools (diarrhea) and severe abdominal cramps. This may result in a clinically significant loss of fluid and electrolytes, particularly potassium, which may require medical attention.


Q: Is Alkalax available only by prescription?

A: Alkalax is generally available Over-the-Counter (OTC) for adult use. However, a prescription or medical supervision may be required, particularly when treating younger children or when using it as part of a bowel preparation procedure.


Q: Do studies suggest Alkalax is generally well-tolerated?

A: Studies and regulatory labeling suggest the medication is generally well-tolerated when taken as directed. However, like all medications, it is associated with common gastrointestinal side effects such as abdominal pain and diarrhea.


Q: How long does it take for Alkalax to completely leave the body?

A: The active metabolite of Bisacodyl that is absorbed into the bloodstream has an elimination half-life of approximately 16 hours. However, the primary laxative effect is local and occurs much sooner than the complete clearance of the drug from the body.


Q: Is Alkalax ever used in hospital settings?

A: Yes, regulatory documents and medical sources confirm that Alkalax is used to empty the bowels as a component of bowel preparation before specific medical procedures or surgeries, such as a colonoscopy.


Q: Can Alkalax cause drowsiness or affect driving?

A: Regulatory documents do not specifically list 'drowsiness' but do report uncommon side effects of dizziness and syncope (fainting). These effects are often linked to a vasovagal response to abdominal discomfort. Official guidance notes that users should be aware of this possibility.


Q: What parts of the digestive system does Alkalax primarily target?

A: Alkalax is designed to be a locally acting laxative. Its primary site of action is the mucosa of the large intestine (colon) and the rectum, where it stimulates muscle contraction.


Q: Is Alkalax the same thing as a stool softener?

A: No. Alkalax is a stimulant laxative that promotes movement by increasing muscle activity. This mechanism is distinct from a stool softener, which works by increasing the water and fat content in the stool to make it easier to pass.


Q: Is Alkalax approved in countries outside of the US?

A: Yes, Bisacodyl, the active ingredient in Alkalax, is regulated and approved for use in many countries globally. Its documentation is overseen by international authorities such as the MHRA in the UK and the TGA in Australia.


Q: Does taking Alkalax require any special diet changes?

A: Official regulatory documents do not mandate special, restrictive diet changes beyond the specific instruction to avoid taking the oral tablet with milk products within one hour. Patients are generally advised to maintain adequate hydration.


Q: Is Alkalax safe to take with common pain relievers like Tylenol or Advil?

A: Official product labeling does not list specific interactions with common pain relievers such as Acetaminophen (Tylenol) or Ibuprofen (Advil). However, a general precaution recommends taking Alkalax 2 hours before or after other drugs.


Q: Is Alkalax a drug that is considered high-risk by regulatory bodies?

A: Regulatory bodies have published warnings related to overuse and long-term use due to the associated risks of dependence and electrolyte imbalance. These warnings emphasize that the product is intended for short-term, occasional use only.


Q: Can Alkalax affect blood pressure?

A: Regulatory sources list syncope (fainting) as an uncommon side effect. This event is attributed to a vasovagal response triggered by abdominal pain or discomfort, which may involve a sudden, temporary drop in blood pressure.

How should Alkalax be stored and disposed of?

Official Storage and Disposal Requirements

Alkalax (Bisacodyl) must be stored and disposed of according to specific requirements outlined in official regulatory labeling to ensure product stability and environmental safety.

Storage/Disposal Requirement Official Statement Summary
Temperature & Environment Store at controlled room temperature (20 C to 25 C or 68 F to 77 F). Do not store above 25 C.
Integrity Protection Keep in the original package and protect the product from moisture and excessive humidity.
Child Safety Keep out of the sight and reach of children at all times.
Disposal Instructions Unused or expired medication should be discarded via an official drug take-back program or mail-back envelope. Do not dispose of the product in wastewater or the toilet.

These mandated conditions ensure the medicine remains stable until its expiration date and that disposal is executed in compliance with local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alkalax found in:

A-Z Index: